Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Neoadjuvant Therapy|Neoplasm Staging|Estrogen Receptor|Histological Grade|HER2|Prognosis|Predictive Value of Tests
Sponsor: Peking University First Hospital